Don't miss our holiday offer - up to 50% OFF!
Retatrutide: The Triple-Agonist Peptide in Metabolic Research
A triple-agonist peptide notable for targeting three receptor systems.
Retatrutide is one of the most-discussed compounds in current metabolic research — notable because it targets three receptor systems at once, an unusual “triple-agonist” design.
What makes it unique
Retatrutide is studied as an agonist at the GLP-1, GIP, and glucagon receptors. This three-way mechanism sets it apart from single- and dual-agonist compounds in the research literature.
Why researchers study it
Metabolic research examines triple agonism to understand how simultaneously engaging these pathways affects energy metabolism and glucose regulation in study models.
Research standards
For a compound studied at precise doses in research settings, verified identity and purity are essential — per-batch COAs and third-party HPLC testing.
Research-grade Retatrutide from Prestige Sciences — ≥99% purity by HPLC, a Certificate of Analysis on every batch, U.S.-shipped with insured delivery.
For laboratory and research use only. Not for human or veterinary consumption. This article is educational and describes published research; it is not medical advice and makes no product claims.